Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
250 participants
INTERVENTIONAL
2025-12-31
2026-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Clinical Comparison of Senofilcon A and Stenfilcon A Contact Lenses
NCT02643004
Evaluation of the Performance of Different Daily Disposable Lens Designs in Habitual Soft Contact Lens Wearers
NCT04668989
Multi-Center Clinical Evaluation of Two Daily Disposable Contact Lenses
NCT01898260
Clinical Performance of Two Daily Disposable Silicone Hydrogel Contact Lenses
NCT05554640
A Clinical Comparison of Three Soft Daily Disposable Contact Lenses
NCT02920983
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
comfilcon A lens
Participants will wear thirteen different types of study contact lenses, in a randomized order of testing for the thirteen study contact lens types.
comfilcon A lens
Participants will be randomized to wear comfilcon A soft contact lens for 10 hours.
verofilcon A lens
Participants will wear thirteen different types of study contact lenses, in a randomized order of testing for the thirteen study contact lens types.
verofilcon A lens
Participants will be randomized to wear verofilcon A soft contact lens for 10 hours.
serafilcon A lens
Participants will wear thirteen different types of study contact lenses, in a randomized order of testing for the thirteen study contact lens types.
serafilcon A lens
Participants will be randomized to wear serafilcon A soft contact lens for 10 hours.
lehfilcon A lens
Participants will wear thirteen different types of study contact lenses, in a randomized order of testing for the thirteen study contact lens types.
lehfilcon A lens
Participants will be randomized to wear lehfilcon A soft contact lens for 10 hours.
delefilcon A lens
Participants will wear thirteen different types of study contact lenses, in a randomized order of testing for the thirteen study contact lens types.
delefilcon A lens
Participants will be randomized to wear delefilcon A soft contact lens for 10 hours.
senofilcon A lens daily disposable
Participants will wear thirteen different types of study contact lenses, in a randomized order of testing for the thirteen study contact lens types.
senofilcon A daily disposable lens
Participants will be randomized to wear senofilcon A soft contact lens for 10 hours.
senofilcon A lens with blue light technology
Participants will wear thirteen different types of study contact lenses, in a randomized order of testing for the thirteen study contact lens types.
senofilcon A with blue light technology lens
Participants will be randomized to wear senofilcon A soft contact lens for 10 hours.
senofilcon A lens bi-weekly replacement
Participants will wear thirteen different types of study contact lenses, in a randomized order of testing for the thirteen study contact lens types.
senofilcon A bi-weekly lens
Participants will be randomized to wear senofilcon A soft contact lens for 10 hours.
samfilcon A lens
Participants will wear thirteen different types of study contact lenses, in a randomized order of testing for the thirteen study contact lens types.
samfilcon A lens
Participants will be randomized to wear samfilcon A soft contact lens for 10 hours.
kalifilcon A lens
Participants will wear thirteen different types of study contact lenses, in a randomized order of testing for the thirteen study contact lens types.
kalilfilcon A lens
Participants will be randomized to wear kalifilcon A soft contact lens for 10 hours.
fanfilcon A lens
Participants will wear thirteen different types of study contact lenses, in a randomized order of testing for the thirteen study contact lens types.
fanfilcon A lens
Participants will be randomized to wear fanfilcon A soft contact lens for 10 hours.
somofilcon A lens
Participants will wear thirteen different types of study contact lenses, in a randomized order of testing for the thirteen study contact lens types.
somofilcon A lens
Participants will be randomized to wear somofilcon A soft contact lens for 10 hours.
stenfilcon A lens
Participants will wear thirteen different types of study contact lenses, in a randomized order of testing for the thirteen study contact lens types.
stenfilcon A lens
Participants will be randomized to wear stenfilcon A soft contact lens for 10 hours.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
somofilcon A lens
Participants will be randomized to wear somofilcon A soft contact lens for 10 hours.
stenfilcon A lens
Participants will be randomized to wear stenfilcon A soft contact lens for 10 hours.
fanfilcon A lens
Participants will be randomized to wear fanfilcon A soft contact lens for 10 hours.
comfilcon A lens
Participants will be randomized to wear comfilcon A soft contact lens for 10 hours.
verofilcon A lens
Participants will be randomized to wear verofilcon A soft contact lens for 10 hours.
serafilcon A lens
Participants will be randomized to wear serafilcon A soft contact lens for 10 hours.
lehfilcon A lens
Participants will be randomized to wear lehfilcon A soft contact lens for 10 hours.
delefilcon A lens
Participants will be randomized to wear delefilcon A soft contact lens for 10 hours.
senofilcon A daily disposable lens
Participants will be randomized to wear senofilcon A soft contact lens for 10 hours.
senofilcon A with blue light technology lens
Participants will be randomized to wear senofilcon A soft contact lens for 10 hours.
senofilcon A bi-weekly lens
Participants will be randomized to wear senofilcon A soft contact lens for 10 hours.
samfilcon A lens
Participants will be randomized to wear samfilcon A soft contact lens for 10 hours.
kalilfilcon A lens
Participants will be randomized to wear kalifilcon A soft contact lens for 10 hours.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Habitual soft spherical contact lens wearer (current prescription)
3. Refractive error of -6.00 to -0.50DS or +0.50 to +6.00DS and less than or equal to 0.75DC as vertexed to the corneal plane
4. Anisometropia no greater than 1.50D, based on vertexed manifest refraction spherical equivalent
5. Can achieve visual acuity of at least 20/25 in each eye with spherical equivalent manifest refraction
Exclusion Criteria
2. Use of systemic or ocular medication that would contraindicate contact lens wear
3. Used gas permeable/hard contact lenses (including orthokeratology) in the previous 3 months
4. Participation in a contact lens or lens care product trial in the previous 30 days
18 Years
45 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
CooperVision International Limited (CVIL)
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Pete Kollbaum, OD, PhD
Role: PRINCIPAL_INVESTIGATOR
Indiana University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Indiana University
Bloomington, Indiana, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Pete Kollbaum, OD, PhD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
EX-MKTG-167
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.